The Preclinical and First-inHuman Study of iPSC-Derived Human Forebrain Neural Progenitor Cell InjectionhNPC01 in Treating Chronic Ischemic Stroke

被引:0
|
作者
Fan, Jing [1 ]
Wang, Anxin [2 ]
Ren, Fang [1 ,2 ]
Yan, Yinggang [1 ,2 ]
Zhang, Shuning [1 ,2 ]
Wang, Jasmine [3 ]
机构
[1] Hopstem Biotechnol, Houston, TX USA
[2] Hopstem Bioengn, Hangzhou, Peoples R China
[3] Hopstem Biotechnol, Clarksburg, MD USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
LBA-34
引用
收藏
页码:16 / 16
页数:1
相关论文
共 2 条
  • [1] The Preclinical and First-in-Human Study of iPSC-Derived Human Forebrain Neural Progenitor Cell Injection-hNPC01 in Treating Chronic Ischemic Stroke
    Fan, Jing
    Wang, Anxin
    Ren, Fang
    Yan, Yinggang
    Zhang, Shuning
    Wang, Jasmine
    MOLECULAR THERAPY, 2024, 32 (04) : 419 - 419
  • [2] First-in-human Phase 1/2a Study Of Intracerebral Transplantation Using Embryonic-derived Neural Stem Cells (NR1) For Chronic Ischemic Stroke
    Steinberg, Gary K.
    Bet, Anthony
    Williams, Jennifer
    McDonald, Kathy
    Diaz, Robert
    Samos, Cindy
    Trisler, Kirk
    Weissinger, Judy
    Coburn, Maria L.
    Tong, Elizabeth
    Schwartz, Neil E.
    STROKE, 2023, 54